{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:00:35Z","timestamp":1773010835640,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T00:00:00Z","timestamp":1421884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12913-015-0681-y","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T10:44:39Z","timestamp":1421837079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults"],"prefix":"10.1186","volume":"15","author":[{"given":"Kayoko","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,22]]},"reference":[{"key":"681_CR1","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JE Portielje","year":"2001","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549\u201354.","journal-title":"Blood"},{"key":"681_CR2","first-page":"433","volume":"53","author":"K Fujimura","year":"2012","unstructured":"Fujimura K, Miyakawa Y, Kurata Y, Kuwana M, Tomiyama Y, Murata M. Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. Rinsho Ketsueki. 2012;53:433\u201342 (in Japanese).","journal-title":"Rinsho Ketsueki"},{"key":"681_CR3","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"K Kojouri","year":"2004","unstructured":"Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623\u201334.","journal-title":"Blood"},{"key":"681_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","volume":"371","author":"DJ Kuter","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395\u2013403.","journal-title":"Lancet"},{"key":"681_CR5","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"681_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u201386.","journal-title":"Blood"},{"key":"681_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","volume":"146","author":"DM Arnold","year":"2007","unstructured":"Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25\u201333.","journal-title":"Ann Intern Med"},{"key":"681_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12185-011-0894-8","volume":"94","author":"LH Lee","year":"2011","unstructured":"Lee LH, Caguioa P, Chin NS, Chiou TJ, Lee JW, Miyakawa Y, et al. Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region. Int J Hematol. 2011;94:142\u20139.","journal-title":"Int J Hematol"},{"issue":"Suppl 2","key":"681_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3310\/hta13suppl2\/09","volume":"13","author":"G Mowatt","year":"2009","unstructured":"Mowatt G, Boachie C, Crowther M, Fraser C, Hern\u00e1ndez R, Jia X, et al. Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal. Health Technol Assess. 2009;13 Suppl 2:63\u20138.","journal-title":"Health Technol Assess"},{"key":"681_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/11591550-000000000-00000","volume":"30","author":"D Boyers","year":"2012","unstructured":"Boyers D, Jia X, Jenkinson D, Mowatt G. Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal. Pharmacoeconomics. 2012;30:483\u201395.","journal-title":"Pharmacoeconomics"},{"key":"681_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40258-013-0044-y","volume":"11","author":"D Lee","year":"2013","unstructured":"Lee D, Thornton P, Hirst A, Kutikova L, Deuson R, Brereton N. Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland. Appl Health Econ Health Policy. 2013;11:457\u201369.","journal-title":"Appl Health Econ Health Policy"},{"key":"681_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12185-012-1065-2","volume":"95","author":"Y Shirasugi","year":"2012","unstructured":"Shirasugi Y, Ando K, Miyazaki K, Tomiyama Y, Iwato K, Okamoto S, et al. An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5\u00a0years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP). Int J Hematol. 2012;95:652\u20139.","journal-title":"Int J Hematol"},{"key":"681_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.7326\/0003-4819-151-8-200910200-00008","volume":"151","author":"RW Thomsen","year":"2009","unstructured":"Thomsen RW, Schoonen WM, Farkas DK, Riis A, Jacobsen J, Fryzek JP, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009;151:546\u201355.","journal-title":"Ann Intern Med."},{"key":"681_CR14","unstructured":"Assessment report of romiplostim [\n                    http:\/\/www.info.pmda.go.jp\/shinyaku\/P201100020\/230124000_22300AMX00437_A100_2.pdf\n                    \n                  ] (in Japanese)"},{"key":"681_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12185-013-1328-6","volume":"97","author":"M Wang","year":"2013","unstructured":"Wang M, Zhang M, Zhou J, Wu Z, Zeng K, Peng B, et al. Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. Int J Hematol. 2013;97:610\u20136.","journal-title":"Int J Hematol"},{"key":"681_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/ajh.23272","volume":"87","author":"F Zaja","year":"2012","unstructured":"Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, et al. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia. Am J Hematol. 2012;87:886\u20139.","journal-title":"Am J Hematol"},{"key":"681_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11239-008-0208-z","volume":"27","author":"S Pasa","year":"2009","unstructured":"Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura. J Thromb Thrombolysis. 2009;27:329\u201333.","journal-title":"J Thromb Thrombolysis"},{"key":"681_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","volume":"112","author":"B Godeau","year":"2008","unstructured":"Godeau B, Porcher R, Fain O, Lefr\u00e8re F, Fenaux P, Cheze S, et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008;112:999\u20131004.","journal-title":"Blood"},{"key":"681_CR19","first-page":"1424","volume":"78","author":"K Ashizawa","year":"2001","unstructured":"Ashizawa K, Eguchi K. Appearance frequency and time of steroid side effect. Rinsho Kenkyu. 2001;78:1424\u20136 (in Japanese).","journal-title":"Rinsho Kenkyu"},{"key":"681_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12185-012-1088-8","volume":"96","author":"R Stasi","year":"2012","unstructured":"Stasi R, Murali M, Michel M, Viallard JF, Giagounidis A, Janssens A, et al. Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care. Int J Hematol. 2012;96:26\u201333.","journal-title":"Int J Hematol"},{"key":"681_CR21","unstructured":"Ministry of Health, Labor and Welfare. abridged life table 2011 version [\n                    http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/life\/life10\/\n                    \n                  ] (in Japanese)"},{"key":"681_CR22","unstructured":"Guidelines for economic evaluation of healthcare technologies in Japan. Tokyo: Research group on economic evaluation for Japanese public medical benefit; 2013. \n                    http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-12404000-Hokenkyoku-Iryouka\/0000033418.pdf\n                    \n                   (in Japanese)"},{"key":"681_CR23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2009.05.006","volume":"31","author":"F Xie","year":"2009","unstructured":"Xie F, Blackhouse G, Assasi N, Campbell K, Levin M, Bowen J, et al. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura. Clin Ther. 2009;31:1082\u201391.","journal-title":"Clin Ther."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-015-0681-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0681-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:39:07Z","timestamp":1551184747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-015-0681-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1186\/s12913-015-0681-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,22]]},"assertion":[{"value":"21 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}